Institutional members access full text with Ovid®

Share this article on:

10 Questions About 4-Aminopyridine and the Treatment of Multiple Sclerosis

Bever, Christopher T. Jr MD

doi: 10.1097/NRL.0b013e3181679be5
10 Questions

From the Research and Neurology Services, VA Maryland Healthcare System, VA Multiple Sclerosis Center of Excellence-East, Baltimore, Maryland; and Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland.

Reprints: Christopher T. Bever Jr, MD, Department of Neurology, UMH, Room N4W46, 22 South Greene Street, Baltimore, MD 21201. E-mail:

© 2009 Lippincott Williams & Wilkins, Inc.